Assessment of pipeline activities around client’s area of interest to support strategic decisions
A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. They wished to identify currently active T-Cell Receptor (TCR) products in research and development for cancer treatment.
- Detailed Assessment of pipeline activity of T-Cell Receptor (TCR) products
- Clinical Trial Assessment of Clinical Stage products of T-Cell Receptor (TCR) arena
- Company Assessment via Funding/Collaboration/Partnership Analysis
- Analyst Comments on R&D developments
- Detailed pipeline profiles of T-Cell Receptor (TCR) products
- Additional comments on Inactive (Discontinued and Dormant) products.
- Therapeutic assessment of active pipeline products
- Detailed profiles of Companies with key coverage of collaboration/partnering activities